Concurrent chemoradiotherapy in the management of advanced nasopharyngeal carcinoma: current status.
about
Concurrent chemoradiotherapy with carboplatin followed by carboplatin and 5-fluorouracil in locally advanced nasopharyngeal carcinoma.Indole-3-carbinol inhibits nasopharyngeal carcinoma cell growth in vivo and in vitro through inhibition of the PI3K/Akt pathwayThe effect of transforming growth factor-beta1 on nasopharyngeal carcinoma cells: insensitive to cell growth but functional to TGF-beta/Smad pathwayRole of eIF3a in regulating cisplatin sensitivity and in translational control of nucleotide excision repair of nasopharyngeal carcinoma.The pattern of relapse and survival of elective irradiation of the upper neck for stage N0 nasopharyngeal carcinoma.No association between TGF-β1 polymorphisms and risk of nasopharyngeal carcinoma in a large North African case-control studyγ-secretase inhibition combined with cisplatin enhances apoptosis of nasopharyngeal carcinoma cells4EGI-1 induces apoptosis and enhances radiotherapy sensitivity in nasopharyngeal carcinoma cells via DR5 induction on 4E-BP1 dephosphorylationBenefit of percutaneous endoscopic gastrostomy in patients undergoing definitive chemoradiotherapy for locally advanced nasopharyngeal carcinoma(68)Ga-DOTA-peptide: A novel molecular biomarker for nasopharyngeal carcinoma.MicroRNA-152 Targets Phosphatase and Tensin Homolog to Inhibit Apoptosis and Promote Cell Migration of Nasopharyngeal Carcinoma Cells.Role of STAT3/5 and Bcl-2/xL in 2-methoxyestradiol-induced endoreduplication of nasopharyngeal carcinoma cells.(68)Ga-DOTA (0)-Tyr (3)-octreotide positron emission tomography in nasopharyngeal carcinoma.Comparison of narrow-band imaging and conventional nasopharyngoscopy for the screening of unaffected members of families with nasopharyngeal carcinoma.Toxicity of concurrent chemoradiotherapy with cetuximab for locoregionally advanced nasopharyngeal carcinoma.Weekly versus triweekly cisplatin plus intensity-modulated radiotherapy in locally advanced nasopharyngeal carcinoma: A propensity score analysis with a large cohort
P2860
Q33395652-872608F2-9AD4-4E8F-B423-C510C57738D9Q33769512-C3527568-8BF6-4446-9CD2-39B21C9F22BDQ33833162-290C03FD-62A6-4A2C-9A41-06027CD0A9E3Q33916098-C28CCE5C-5A0F-4088-978E-4607C4549200Q35963310-403E3305-4119-4E29-8E25-B402D02634DEQ36161779-8DD7AF7D-04C6-4A23-981A-D73E235321E9Q36224427-716DB316-96C7-404C-82CB-C091261630E6Q37225382-3B456E27-9A13-4BE5-9930-6BE8A9817DEAQ37407412-D6AEEBD9-5E00-49CE-8588-9F96CDF496E8Q38566849-3CA261AD-20A0-4B99-9255-EB79686803C5Q38731400-1A04BCC0-764D-4F39-87C0-F4A0C1AD6C98Q39456688-6A5D95E2-E9B3-4DC1-BF21-6DCB8B406DA7Q42187299-A00AC3B7-C514-4E75-842C-1FB2C8B33EFEQ43830356-396EBE99-C986-4DB5-888F-6154997FBC55Q46383461-C79874C8-96D4-463F-8F1E-9F816A0C39F8Q57493804-A47B331C-9A73-4BCD-A0B5-EB7FD945CAF5
P2860
Concurrent chemoradiotherapy in the management of advanced nasopharyngeal carcinoma: current status.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Concurrent chemoradiotherapy i ...... eal carcinoma: current status.
@en
Concurrent chemoradiotherapy i ...... eal carcinoma: current status.
@nl
type
label
Concurrent chemoradiotherapy i ...... eal carcinoma: current status.
@en
Concurrent chemoradiotherapy i ...... eal carcinoma: current status.
@nl
prefLabel
Concurrent chemoradiotherapy i ...... eal carcinoma: current status.
@en
Concurrent chemoradiotherapy i ...... eal carcinoma: current status.
@nl
P2093
P356
P1476
Concurrent chemoradiotherapy i ...... eal carcinoma: current status.
@en
P2093
Hassan Errihani
Nabil Ismaili
Said Afqir
P356
10.4103/0973-1482.48763
P407
P577
2009-01-01T00:00:00Z